(Q33984662)

English

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

Europe PubMed Central

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

PREDIMED Investigators

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

6 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1750-1757

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Outcome of heart failure with preserved ejection fraction in a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Irbesartan in patients with heart failure and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Heart failure with preserved left ventricular systolic function: a hospital cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Survival of patients with a new diagnosis of heart failure: a population based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Clinical outcome of patients with heart failure and preserved left ventricular function.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Insights into the contemporary epidemiology and outpatient management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Heart failure in patients with preserved and deteriorated left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

"Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Death in heart failure: a community perspective

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33984662&oldid=1866794918"